Cochrane Abstracts
Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants: Cochrane systematic review
Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Continuous Infusion Versus Intermittent Bolus Doses of Indomethacin for Patent Ductus Arteriosus Closure in Symptomatic Preterm Infants: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431618/all/Continuous_infusion_versus_intermittent_bolus_doses_of_indomethacin_for_patent_ductus_arteriosus_closure_in_symptomatic_preterm_infants:_Cochrane_systematic_review. Accessed 17 January 2022.
Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431618/all/Continuous_infusion_versus_intermittent_bolus_doses_of_indomethacin_for_patent_ductus_arteriosus_closure_in_symptomatic_preterm_infants:_Cochrane_systematic_review. Accessed January 17, 2022.
Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431618/all/Continuous_infusion_versus_intermittent_bolus_doses_of_indomethacin_for_patent_ductus_arteriosus_closure_in_symptomatic_preterm_infants:_Cochrane_systematic_review
Continuous Infusion Versus Intermittent Bolus Doses of Indomethacin for Patent Ductus Arteriosus Closure in Symptomatic Preterm Infants: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2022 January 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431618/all/Continuous_infusion_versus_intermittent_bolus_doses_of_indomethacin_for_patent_ductus_arteriosus_closure_in_symptomatic_preterm_infants:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants: Cochrane systematic review
ID - 431618
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431618/all/Continuous_infusion_versus_intermittent_bolus_doses_of_indomethacin_for_patent_ductus_arteriosus_closure_in_symptomatic_preterm_infants:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
